New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and fasterGhent, Belgium, 6 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. T.
Cell therapy has become an indispensable part of medicine today. With this form of immunotherapy you use your own body cells as medicine to fight the disease.